MILTON SCHLACHMAN, M.D., F.A.C.P.
The advent of the anticoagulants in the treatment of coronary occlusion was received with almost universal enthusiasm when the reports of Nichol, Wright and Peters appeared in the medical literature.1-8 However, the intervening years have somewhat modified in the minds of many physicians the original acceptance of the value of anticoagulants, and reports have appeared which raise some doubt as to their usefulness in this condition.9-15
Nevertheless, many leaders in the field of anticoagulant therapy still retain their original faith in these drugs, and they have implied that the use of anticoagulants in patients with impending coronary occlusion or with
MILTON SCHLACHMAN. THE FAILURE OF ANTICOAGULANT THERAPY TO PREVENT MYOCARDIAL INFARCTION IN PATIENTS WITH PREMONITORY SYMPTOMS OF AN IMPENDING CORONARY OCCLUSION(THE FAILURE OF ANTICOAGULANT THERAPY TO PREVENT MYOCARDIAL INFARCTION IN PATIENTS WITH PREMONITORY SYMPTOMS OF AN IMPENDING CORONARY OCCLUSION*). Ann Intern Med. 1957;46:728–735. doi: 10.7326/0003-4819-46-4-728
Download citation file:
Published: Ann Intern Med. 1957;46(4):728-735.
Acute Coronary Syndromes, Cardiology, Coronary Heart Disease, Emergency Medicine.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use